{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:06:14Z","timestamp":1788869174114,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10067-024-06984-7","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T10:01:36Z","timestamp":1714903296000},"page":"1855-1863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Jin","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5657-0705","authenticated-orcid":false,"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,5]]},"reference":[{"key":"6984_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0889-857X(05)70201-5","volume":"27","author":"SE Gabriel","year":"2001","unstructured":"Gabriel SE (2001) The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 27:269\u2013281","journal-title":"Rheum Dis Clin North Am"},{"key":"6984_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J et al (2010) Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 49:1483\u20131489","journal-title":"Rheumatology (Oxford)"},{"key":"6984_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J et al (2011) Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 183:372\u2013378","journal-title":"Am J Respir Crit Care Med"},{"key":"6984_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH et al (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62:1583\u20131591","journal-title":"Arthritis Rheum"},{"key":"6984_CR5","doi-asserted-by":"crossref","unstructured":"Yamakawa H, Ogura T, Kameda H et al (2021) Decision-making strategy for the treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD)[J]. J Clin Med\u00a010(17):3806","DOI":"10.3390\/jcm10173806"},{"key":"6984_CR6","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s10067-021-05585-y","volume":"40","author":"DS Fotoh","year":"2021","unstructured":"Fotoh DS, Helal A, Rizk MS, Esaily HA (2021) Serum Krebs von den Lungen-6 and lung ultrasound B lines as potential diagnostic and prognostic factors for rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 40:2689\u20132697","journal-title":"Clin Rheumatol"},{"key":"6984_CR7","doi-asserted-by":"crossref","unstructured":"Florescu A, Gherghina FL, Musetescu AE et al (2022) Novel biomarkers, diagnostic and therapeutic approach in rheumatoid arthritis interstitial lung disease-a narrative review[J]. Biomedicines\u00a010(6):1367","DOI":"10.3390\/biomedicines10061367"},{"key":"6984_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","volume":"106","author":"S Mori","year":"2012","unstructured":"Mori S, Koga Y, Sugimoto M (2012) Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med 106:1591\u20131599","journal-title":"Respir Med"},{"key":"6984_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/03009742.2018.1477989","volume":"48","author":"T Matsuo","year":"2019","unstructured":"Matsuo T, Hashimoto M, Ito I, Kubo T, Uozumi R, Furu M et al (2019) Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study. Scand J Rheumatol 48:87\u201394","journal-title":"Scand J Rheumatol"},{"key":"6984_CR10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","volume":"191","author":"TJ Doyle","year":"2015","unstructured":"Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC et al (2015) Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers. Am J Respir Crit Care Med 191:1403\u20131412","journal-title":"Am J Respir Crit Care Med"},{"key":"6984_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/art.38904","volume":"67","author":"J Chen","year":"2015","unstructured":"Chen J, Doyle TJ, Liu Y, Aggarwal R, Wang X, Shi Y et al (2015) Biomarkers of rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol 67:28\u201338","journal-title":"Arthritis Rheumatol"},{"key":"6984_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/art.37881","volume":"65","author":"L Harlow","year":"2013","unstructured":"Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Dellaripa PF, Oddis CV et al (2013) Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum 65:869\u2013879","journal-title":"Arthritis Rheum"},{"key":"6984_CR13","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","volume":"34","author":"JF Restrepo","year":"2015","unstructured":"Restrepo JF, del Rincon I, Battafarano DF, Haas RW, Doria M, Escalante A (2015) Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis. Clin Rheumatol 34:1529\u20131536","journal-title":"Clin Rheumatol"},{"key":"6984_CR14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","volume":"53","author":"CA Kelly","year":"2014","unstructured":"Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN et al (2014) Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study. Rheumatology (Oxford) 53:1676\u20131682","journal-title":"Rheumatology (Oxford)"},{"key":"6984_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","volume":"30","author":"HM Habib","year":"2011","unstructured":"Habib HM, Eisa AA, Arafat WR, Marie MA (2011) Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol 30:217\u2013221","journal-title":"Clin Rheumatol"},{"key":"6984_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40744-021-00288-x","volume":"8","author":"M Zheng","year":"2021","unstructured":"Zheng M, Lou A, Zhang H, Zhu S, Yang M, Lai W (2021) Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid arthritis-associated interstitial lung disease in the Chinese population. Rheumatol Ther 8:517\u2013527","journal-title":"Rheumatol Ther"},{"key":"6984_CR17","doi-asserted-by":"crossref","unstructured":"Mena-Vazquez N, Godoy-Navarrete FJ, Lisbona-Montanez JM et al (2023) Inflammatory biomarkers in the diagnosis and prognosis of rheumatoid arthritis-associated interstitial lung disease[J]. Int J Mol Sci\u00a024(7):6800","DOI":"10.3390\/ijms24076800"},{"key":"6984_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","volume":"11","author":"JJ Solomon","year":"2023","unstructured":"Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I et al (2023) Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir Med 11:87\u201396","journal-title":"Lancet Respir Med"},{"key":"6984_CR19","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"6984_CR20","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.40904","volume":"71","author":"JA Sparks","year":"2019","unstructured":"Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM et al (2019) Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol 71:1472\u20131482","journal-title":"Arthritis Rheumatol"},{"key":"6984_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.mayocp.2018.09.002","volume":"94","author":"I Mira-Avendano","year":"2019","unstructured":"Mira-Avendano I, Abril A, Burger CD, Dellaripa PF, Fischer A, Gotway MB et al (2019) Interstitial lung disease and other pulmonary manifestations in connective tissue diseases. Mayo Clin Proc 94:309\u2013325","journal-title":"Mayo Clin Proc"},{"key":"6984_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.rdc.2014.12.004","volume":"41","author":"ZX Yunt","year":"2015","unstructured":"Yunt ZX, Solomon JJ (2015) Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am 41:225\u2013236","journal-title":"Rheum Dis Clin North Am"},{"key":"6984_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3899\/jrheum.171315","volume":"46","author":"K Raimundo","year":"2019","unstructured":"Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A et al (2019) Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality. J Rheumatol 46:360\u2013369","journal-title":"J Rheumatol"},{"key":"6984_CR24","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Lokke A, Bendstrup E et al (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76:1700\u20131706","journal-title":"Ann Rheum Dis"},{"key":"6984_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/1744666X.2021.1905524","volume":"17","author":"A Manfredi","year":"2021","unstructured":"Manfredi A, Cassone G, Luppi F, Atienza-Mateo B, Cavazza A, Sverzellati N et al (2021) Rheumatoid arthritis related interstitial lung disease. Expert Rev Clin Immunol 17:485\u2013497","journal-title":"Expert Rev Clin Immunol"},{"key":"6984_CR26","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/thx.56.8.622","volume":"56","author":"JK Dawson","year":"2001","unstructured":"Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR (2001) Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 56:622\u2013627","journal-title":"Thorax"},{"key":"6984_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000442890","volume":"91","author":"KE Paschalaki","year":"2016","unstructured":"Paschalaki KE, Jacob J, Wells AU (2016) Monitoring of lung involvement in rheumatologic disease. Respiration 91:89\u201398","journal-title":"Respiration"},{"key":"6984_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10067-018-04421-0","volume":"38","author":"CS Correia","year":"2019","unstructured":"Correia CS, Briones MR, Guo R, Ostrowski RA (2019) Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease. Clin Rheumatol 38:1201\u20131206","journal-title":"Clin Rheumatol"},{"key":"6984_CR29","first-page":"564","volume":"34","author":"M Sebastiani","year":"2016","unstructured":"Sebastiani M, Manfredi A, Cerri S, Della Casa G, Luppi F, Ferri C (2016) Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease. Clin Exp Rheumatol 34:564\u2013565","journal-title":"Clin Exp Rheumatol"},{"key":"6984_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","volume":"36","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li H, Wu N, Dong X, Zheng Y (2017) Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 36:817\u2013823","journal-title":"Clin Rheumatol"},{"key":"6984_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/acr.22765","volume":"68","author":"J Wang","year":"2016","unstructured":"Wang J, Devenport J, Low JM, Yu D, Hitraya E (2016) Relationship between baseline and early changes in C-reactive protein and interleukin-6 levels and clinical response to tocilizumab in rheumatoid arthritis. Arthritis Care Res (Hoboken) 68:882\u2013885","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6984_CR32","doi-asserted-by":"publisher","first-page":"105948","DOI":"10.1016\/j.rmed.2020.105948","volume":"166","author":"X Wu","year":"2020","unstructured":"Wu X, Xu L, Cheng Q, Nie L, Zhang S, Du Y et al (2020) Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: a monocentric cross-sectional study. Respir Med 166:105948","journal-title":"Respir Med"},{"key":"6984_CR33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/art.39974","volume":"69","author":"KP Liao","year":"2017","unstructured":"Liao KP, Sparks JA, Hejblum BP, Kuo IH, Cui J, Lahey LJ et al (2017) Phenome-wide association study of autoantibodies to citrullinated and noncitrullinated epitopes in rheumatoid arthritis. Arthritis Rheumatol 69:742\u2013749","journal-title":"Arthritis Rheumatol"},{"key":"6984_CR34","doi-asserted-by":"publisher","first-page":"e0232978","DOI":"10.1371\/journal.pone.0232978","volume":"15","author":"J Avouac","year":"2020","unstructured":"Avouac J, Cauvet A, Steelandt A, Shirai Y, Elhai M, Kuwana M et al (2020) Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease. PLoS One 15:e0232978","journal-title":"PLoS One"},{"key":"6984_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1164\/rccm.201404-0603OC","volume":"193","author":"R Molina","year":"2016","unstructured":"Molina R, Marrades RM, Auge JM, Escudero JM, Vinolas N, Reguart N et al (2016) Assessment of a combined panel of six serum tumor markers for lung cancer. Am J Respir Crit Care Med 193:427\u2013437","journal-title":"Am J Respir Crit Care Med"},{"key":"6984_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/CBM-2009-0126","volume":"6","author":"J Schneider","year":"2010","unstructured":"Schneider J (2010) Early detection of lung cancers - comparison of computed tomography, cytology and fuzzy-based tumor markers panels. Cancer Biomark 6:149\u2013162","journal-title":"Cancer Biomark"},{"key":"6984_CR37","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","volume":"5","author":"TM Maher","year":"2017","unstructured":"Maher TM, Oballa E, Simpson JK, Porte J, Habgood A, Fahy WA et al (2017) An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med 5:946\u2013955","journal-title":"Lancet Respir Med"},{"key":"6984_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2177\/jsci.19.128","volume":"19","author":"S Yamamoto","year":"1996","unstructured":"Yamamoto S, Kobayashi S, Tanaka M, Akimoto T, Takasaki Y (1996) Serum CA 19\u20139 levels in rheumatic diseases with interstitial pneumonia. Nihon Rinsho Meneki Gakkai Kaishi 19:128\u2013135","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"6984_CR39","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1378\/chest.09-0510","volume":"136","author":"RM Strieter","year":"2009","unstructured":"Strieter RM, Mehrad B (2009) New mechanisms of pulmonary fibrosis. Chest 136:1364\u20131370","journal-title":"Chest"},{"key":"6984_CR40","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.rmed.2003.10.010","volume":"98","author":"J Fujita","year":"2004","unstructured":"Fujita J, Ohtsuki Y, Bandoh S, Takashima H, Ueda Y, Wu F et al (2004) Elevation of cytokeratin 19 fragment (CYFRA 21\u20131) in serum of patients with radiation pneumonitis: possible marker of epithelial cell damage. Respir Med 98:294\u2013300","journal-title":"Respir Med"},{"key":"6984_CR41","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038","journal-title":"Lancet"},{"key":"6984_CR42","doi-asserted-by":"crossref","unstructured":"Juge PA, Borie R, Kannengiesser C et al (2017) Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis[J]. Eur Respir J\u00a049(5):1602314","DOI":"10.1183\/13993003.02314-2016"},{"key":"6984_CR43","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/1744666X.2020.1803064","volume":"16","author":"A Manfredi","year":"2020","unstructured":"Manfredi A, Luppi F, Cassone G, Vacchi C, Salvarani C, Sebastiani M (2020) Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia. Expert Rev Clin Immunol 16:751\u2013770","journal-title":"Expert Rev Clin Immunol"},{"key":"6984_CR44","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/art.40574","volume":"70","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V (2018) The lung in rheumatoid arthritis: focus on interstitial lung disease. Arthritis Rheumatol 70:1544\u20131554","journal-title":"Arthritis Rheumatol"},{"key":"6984_CR45","doi-asserted-by":"publisher","first-page":"103056","DOI":"10.1016\/j.autrev.2022.103056","volume":"21","author":"M Akiyama","year":"2022","unstructured":"Akiyama M, Kaneko Y (2022) Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev 21:103056","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06984-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-06984-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06984-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T19:03:23Z","timestamp":1721675003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-06984-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,5]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["6984"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-06984-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,5]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human studies have been approved by the ethics committee on human research of Beijing Tiantan Hospital (No. KY2022-225\u201302) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}